Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Walgreens is about to announce Q2 results on March 31st 2021, which might entail a positive surprise. WBA will get $6bn in cash and has its eyes fixed on a new target. Announcement of a new M&A deal is likely, which will be positive for the stock.

Walgreens: Significant Upside Despite Recent Share Price Increase

Although WBA has been plagued over the past few years, last Q3 could have established the bottom in a turnaround story for the company. Near-term positives that have arisen include omni-channel strength, international pharmacy recovery, vaccinations driving traffic, and debt paydown.

Walgreens: More Reasons To Be Positive

Boeing

Caterpillar

Chevron

Honeywell

Intel

The Dow Jones Industrial Average is hovering at record highs and a handful of its components are performing even better.

Walgreens and these other Dow stocks are having their best quarters in decades

Walgreens Boots Alliance Inc (NASDAQ:WBA) is in the hot seat today, following news that Arkansas Attorney General Leslie Rutledge is suing the company for its alleged role in fueling the state's opioid crisis, and violating its Deceptive Trade Practices.

Walgreens Under Pressure After Arkansas Opioid Lawsuit

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens announced today that it will participate in the first-ever Localization Summit, a virtual showcase for diverse, local and regional businesses and entrepreneurs to share their retail offerings with the merchants of the national drugstore chain. The virtual event, hosted by ECRM, provides local vendors, the opportunity to connect with Walgreens Merchandising team, share their product, and receive feedback with the ultimate goal of being stocked on Walgr

Walgreens Calls for Diverse Local and Regional Vendor Participation Nationwide at the Localization Summit

American Express

Cisco Systems

Disney

Johnson & Johnson

JPMorgan Chase & Co

Lovesac Company

Tidewater

UnitedHealth Group

Two new breakout stocks for Week 11 of 2021 with better than 10% short-term upside potential. This past week both DSSI +11.4% and JNCE +27.1% gained more than 10% while the average return to the close for all 4 selections was a gain of +6.09%.

Week 11 MDA Breakout Stocks - March 2021: Short-Term Picks To Give You An Edge

Goldman Sachs

Dow Jones has been hitting new record highs lately on an expected economic surge as cyclical sectors are outperforming after being beaten down badly amid the coronavirus crisis.

5 Hottest Stocks in the Dow ETF

WBA stock is trying to find a bottom as investors eye an economic recovery. Is Walgreens stock a buy?

Is WBA Stock A Buy Now, With Economic Recovery In Sight? Walgreens Up 17% In 2021

Walgreens is increasing Covid-19 vaccination to pharmacies in 43 states and jurisdictions.

Walgreens Expands Covid-19 Vaccination To Pharmacies In 39 States

Shares of Walgreens Boots Alliance Inc. gained 0.4% in premarket trading on Tuesday after the company said it has provided approximately 5 million COVID-19 vaccine doses as part of a federal program aimed at vaccinating nursing-home residents and workers. It said it will receive about 1 million more COVID-19 vaccine doses from all three authorized vaccine developers this week.

Walgreens has administered 5 million COVID-19 vaccine shots

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens has provided 5 million COVID-19 vaccinations across long-term care facilities, in stores and through dedicated clinics.

Walgreens Administers 5 Million COVID Vaccinations and Nears Completion of Long-Term Care Facility Program

The stock price of Walgreens Boots Alliance looks attractive at current levels of $47, as it is up a mere 7% from the levels it was on March 23, 2020, when broader markets made a bottom due to the spread of Covid-19. This marks a significant underperformance compared to the S&P which has moved.

Here's Why We Believe Walgreens Stock In Undervalued At $47

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Find Care® introduces 15 new or expanded service providers to address need for comprehensive healthcare during the COVID-19 pandemic.

Walgreens Find Care® Introduces New Service Providers to Address Need for Comprehensive Healthcare During the COVID-19 Pandemic

Altria

Polaris

Stocks have roared higher at 4X their historical rate in recent months. The S&P 500 is 35% overvalued, the dividend aristocrats 15% overvalued. Fortunately, blue-chip bargains are always available if you know where to look. Here, I highlight the safest and best aristocrats for any goal and need.

3 Dividend Aristocrats You Can Safely Buy That Are Set To Fly

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal 2021 second quarter earnings results at 7 a.m. Eastern time, Wednesday, March 31.

Walgreens Boots Alliance Schedules Fiscal 2021 Second Quarter Earnings Announcement for March 31, 2021

CVS Health

Herbalife

3 Pharmacies & Drugstore Stocks to Watch Amid COVID-19 Resurgence

Costco

Walmart

Walgreens has started selling an FDA-authorized COVID-19 saliva test that you can take at home. The Clinical Reference Laboratory (CRL)'s rapid response COVID-19 saliva test costs $119, and is available through Walgreens' online Find Care division.

Walgreens joins Amazon, Costco, and Walmart in selling an FDA-authorized COVID-19 saliva test that you can take at home. It costs $119.

Shares of Walgreens Boots Alliance Inc. gained 0.3% in trading on Thursday, the day after the pharmacy giant said it will begin selling over-the-counter COVID-19 tests developed by the Laboratory Corporation of America Holdings . Labcorp's stock was down 1.8%.

Walgreens to start selling at-home COVID-19 tests

Co-Diagnostics

Co-Diagnostics Inc (NASDAQ:CODX) has confirmed that its patented CoPrimer technology is part of a coronavirus (COVID-19) saliva test that is now available through Walgreens Find Care, a digital health platform on the retailer's website and mobile app. In a statement on Thursday, Dwight Egan, Co-Diagnostics CEO commented: “Co-Diagnostics is proud that our technology will be available on an even more widespread basis following this announcement by our trusted partner CRL, one of the largest privately-held clinical testing laboratories in the U.S.

Co-Diagnostics notes its CoPrimer technology powers coronavirus saliva test now available through Walgreens digital health platform

There are many questions surrounding the future of the pharmacy retailer's business.

How Safe Is Walgreens Boots Alliance and Its Dividend?

Labcorp Holdings Inc

DEERFIELD, Ill. & BURLINGTON, N.C.--(BUSINESS WIRE)--As part of Walgreens ongoing efforts to increase access to COVID-19 testing in communities across the U.S., the company announced today it has entered into an agreement with Labcorp™ to sell Pixel by Labcorp COVID-19 PCR Test Home Collection Kits over-the-counter in up to 6,000 Walgreens stores nationwide beginning in spring of this year. Walgreens is making significant strides to increase on-site testing capacity at more than 5,000 Walgreens

Walgreens to Make Pixel by Labcorp™ COVID-19 PCR Test Home Collection Kit Available Over-The-Counter at Stores Nationwide

Walgreens is growing on-demand delivery offerings with the help of Instacart to those who live in Illinois. The pharmacy retailer has intentions to launch the service throughout the country to almost 8,000 retail locations in future weeks, according to a Tuesday (Feb. 23) announcement.

Walgreens Grows On-Demand Delivery Offerings With Instacart

DEERFIELD, Ill. & SAN FRANCISCO--(BUSINESS WIRE)--Walgreens today announced it is expanding on-demand delivery solutions with Instacart, the leading online grocery platform in North America, to residents across Illinois, with plans to roll out the service nationwide to nearly 8,000 stores over the coming weeks. Customers can now find tens of thousands of Walgreens favorites, including over-the-counter medications, health and wellness, beauty and personal care, household essentials, and convenie

Walgreens Launches Nationwide Rollout of Same-Day Delivery with Instacart

Shares of Walgreens and CVS have appreciated well since late last year, gaining roughly 35% and 20% respectively using September 1, 2020 as a basis.

3 Reasons Why I Favor Walgreens Over CVS

Walgreens Boots Alliance Inc. said Friday that it will receive a weekly allocation of more than 480,000 COVID-19 vaccine doses, starting Feb. 25. The places the drugstore chain supports administration of vaccine include Arizona, Arkansas, Chicago, Connecticut, Georgia, Illinois, Kentucky, Maine, Maryland, Nevada, New Hampshire, New Mexico, New York, New York City, North Carolina, Ohio, Oregon, Puerto Rico, U.S. Virgin Islands, Utah, Vermont, Virginia, West Virginia, Wisconsin and Wyoming.

News for Walgreens Stock (WBA)